For academic and pharma research projects
Microbiome Analysis Services
Ship your samples to our PMP™ service laboratory for accurate, rapid and standardised analysis.
Precision Microbiome Profiling · PMP™
Powering Microbiome Research and Diagnostics
High-throughput, qPCR-based microbiome profiling for researchers, drug developers and health innovators.
Targeted qPCR profiling
Validated assays on Thermo Fisher Scientific’s OpenArray® platform detect selected microbes at species, subspecies and strain level.
Absolute quantification
Results are reported as number of genomes per ng of DNA — not only relative abundance.
Ready-to-use results
No bioinformatics processing is needed on your side. Data arrive ready for interpretation.
Solutions
Find the right solution for your work
Bio-Me offers an end-to-end microbiome workflow — with off-the-shelf solutions and customisation to your specific needs.
For drug developers and clinical researchers
Diagnostics & Drug Development
Profiling for LBP quality control, clinical trial stratification, engraftment monitoring and diagnostic test development.
For companies in preventive and consumer health
Preventive & Consumer Health
End-to-end analysis solutions — from sample collection kit to microbiome profile results.
PMP™ technology
From samples to interpretable results
PMP™ is a targeted qPCR approach on Thermo Fisher Scientific’s OpenArray® platform — an alternative to sequencing that delivers accurate, detailed microbiome information in a high-throughput format. Projects can cover the full workflow or start from purified DNA.
- Step 1
Sample collection
Collection kits, such as fecal sampling on filter paper for stable storage and simple shipping.
- Step 2
DNA extraction
Automated bacterial DNA isolation and quantification following standardised protocols.
- Step 3
PMP™ analysis
Highly parallelised qPCR on OpenArray® with carefully validated, true-to-target assays.
- Step 4
Results
Absolute quantification, delivered ready to use — without bioinformatics steps.
Biomarker discovery
Technology combined with HUNT4 access
Through a special collaboration with HUNT4 — a large-scale, population-based observational cohort — Bio-Me has access to fecal samples and anonymised medical registries. Combined with PMP™, this supports discovery and validation of novel biomarkers and drug targets.
- Individuals with fecal samples
- 13,300
- Health parameters in registries
- 6,000+
Access through collaboration with HUNT4. Figures as stated by Bio-Me.
“We chose Bio-Me as our diagnostic partner based on the performance of the PMP™ technology and their experience in developing microbiome profiling tools with clinical relevance.”
Partners
News
Latest from Bio-Me
17 August 2026
From facial microbiome maps to actionable skin health insights: what a new JID publication shows about PMP™
12 August 2026
Bio-Me has been selected as one of the newest companies to join Nordic Mentor Network for Entrepreneurship – NOME
12 November 2025
Bio-Me AS appoints Dr. Davide Manissero to Board of Directors to accelerate women's health diagnostics strategy
Let’s discuss your microbiome project.
Tell us about your research question, application or analysis needs.